Omur Baysal | Microbiology | Best Researcher Award

Posted on by sciencefather

Prof. Dr. Omur Baysal | Microbiology | Best Researcher Award

Mugla Sitki Kocman University | Turkey

Prof. Dr. Ömür Baysal is a tenured researcher in Molecular Microbiology at Muğla University (Turkey) and an Honorary Professor at the University of Worcester (UK). His work focuses on host-microbe interactions, molecular markers, biological control of pathogens, antibiotic resistance, and bioinformatics (genomics, proteomics, drug discovery). With an H-index of 20, he bridges lab research and computational biology.

Professional profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

  1. High-Impact Research Output

    • Extensive Publications: Over 35+ SCI/SCI-E indexed journal articles, demonstrating consistent contributions to molecular microbiology, plant-pathogen interactions, and bioinformatics.

    • Diverse Research Areas: Expertise spans host-microbe interactions, antibiotic resistance, biocontrol agents, drug discovery, and omics technologies (genomics, proteomics, metagenomics).

    • Recent High-Profile Works (2023-2024):

      • Anticancer Agents in Medical Chemistry (2024) – Machine learning & cancer research.

      • PLoS ONE (2021) – Computational analysis of SARS-CoV-2.

      • Frontiers in Oncology (2023) – Cold plasma therapy in cancer.

  2. International Collaborations & Recognition

    • Honorary Professorship (UK): Affiliation with the University of Worcester strengthens global research ties.

    • Sabbaticals & Invited Research Roles: Worked at USDA/USA, Volcani Center (Israel), CNR (Italy), CIRAD (France), indicating international recognition.

    • Multi-Country Co-Authorships: Collaborations with researchers from Germany, Israel, Italy, UK, Belarus, etc.

  3. Innovative Methodologies

    • Bioinformatics & AI Integration: Use of machine learning, molecular docking, RNA-seq, and metagenomics in pathogen studies.

    • Biocontrol & Sustainable Agriculture: Focus on biological control agents (Bacillus spp.) and host-induced gene silencing (HIGS).

    • Translational Research: Applied studies on drug discovery (HIV-1, breast cancer, SARS-CoV-2).

  4. Strong Academic Metrics

    • H-index: 20 | I-index: 31 (Google Scholar) – Reflects sustained citation impact.

    • Editorial Roles: Serves as a referee for Frontiers in Microbiology, PLOS ONE, Plant Disease (APS), etc.

Education 🎓

  • B.Sc. (1994): Plant Protection Engineering, Akdeniz University, Turkey.

  • M.Sc. (1997): Phytopathology, Akdeniz University.

  • Ph.D. (2001): Plant Pathology (Bacteriology), University of Göttingen, Germany.

  • Postdoc Training (2007–2014): Volcani Center (Israel), CNR Italy, CIRAD France, USDA/University of Florida (USA).

Experience 💼

  • Current Roles:

    • Professor, Molecular Microbiology & Bioinformatics, Muğla University.

    • Honorary Professor, Biosciences, University of Worcester (UK).

  • Expertise: Molecular diagnostics, biocontrol agents, recombinant DNA, protein-ligand docking, and whole-genome/RNA-seq analysis.

Research Interests On Microbiology 🔍

  • Host-microbe interactions

  • Antibiotic resistance mechanisms

  • Biological control of plant pathogens

  • Bioinformatics (genomics, metagenomics, drug discovery)

  • Enzyme enhancement via recombinant tech

Awards & Honors 🏆

  • High-impact publications (31+ SCI-indexed papers).

  • International collaborations (US, EU, Israel).

  • Editorial roles in Frontiers in Microbiology, PLoS ONE, Plant Pathology, etc.

Publications 📚

  • Title: Induction of defence‐related enzymes and resistance by the plant activator acibenzolar‐S‐methyl in tomato seedlings against bacterial canker caused by Clavibacter michiganensis
    Authors: Ö Baysal, EM Soylu, S Soylu
    Year: 2003
    Cited by: 227

  • Title: Induction of disease resistance by the plant activator, acibenzolar-S-methyl (ASM), against bacterial canker (Clavibacter michiganensis subsp. michiganensis) in tomato seedlings
    Authors: S Soylu, Ö Baysal, EM Soylu
    Year: 2003
    Cited by: 164

  • Title: An inhibitory effect of a new Bacillus subtilis strain (EU07) against Fusarium oxysporum f. sp. radicis-lycopersici
    Authors: Ö Baysal, M Çalışkan, Ö Yeşilova
    Year: 2008
    Cited by: 151

  • Title: A Proteomic Approach Provides New Insights into the Control of Soil-Borne Plant Pathogens by Bacillus Species
    Authors: Ö Baysal, D Lai, HH Xu, M Siragusa, M Çalışkan, F Carimi, JAT Da Silva, …
    Year: 2013
    Cited by: 124

  • Title: Molecular Characterization of Fusarium oxysporum f. melongenae by ISSR and RAPD Markers on Eggplant
    Authors: Ö Baysal, M Siragusa, E Gümrükcü, S Zengin, F Carimi, M Sajeva, …
    Year: 2010
    Cited by: 112

  • Title: Chemical composition and antifungal activity of the essential oil of Artemisia annua L. against foliar and soil-borne fungal pathogens
    Authors: EM Soylu, H Yiğitbaş, FM Tok, S Soylu, Ş Kurt, Ö Baysal, AD Kaya
    Year: 2005
    Cited by: 109

  • Title: Induction of oxidants in tomato leaves treated with DL-β-Amino butyric acid (BABA) and infected with Clavibacter michiganensis ssp. michiganensis
    Authors: Ö Baysal, YZ Gürsoy, H Örnek, A Duru
    Year: 2005
    Cited by: 108

  • Title: Acibenzolar-S-methyl induced resistance to Phytophthora capsici in pepper leaves
    Authors: O Baysal, C Turgut, G Mao
    Year: 2005
    Cited by: 75

  • Title: Extract of Hedera helix induces resistance on apple rootstock M26 similar to Acibenzolar-S-methyl against Fire Blight (Erwinia amylovora)
    Authors: Ö Baysal, W Zeller
    Year: 2004
    Cited by: 67

  • Title: Fusarium oxysporum f. sp. lycopersici races and their genetic discrimination by molecular markers in West Mediterranean region of Turkey
    Authors: Ö Baysal, M Siragusa, H İkten, İ Polat, E Gümrükcü, F Yigit, F Carimi, …
    Year: 2009
    Cited by: 61

Conclusion 🌟

Prof. Baysal is a pioneer in molecular plant-microbe interactions, blending wet-lab and computational tools. His work on biocontrol agents, antibiotic resistance, and drug discovery has global impact, supported by international collaborations and high-profile publications. A leader in both academia and applied research.

Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Posted on by sciencefather

Dr. Saeid Amiri Zadeh Fard | Microbiology | Best Researcher Award

Shiraz University of Medical Sciences | Iran

Dr. Saeid Amiri Zadeh Fard is a distinguished biomedical researcher specializing in virology and biotechnology. With extensive experience in viral suppression techniques, particularly short hairpin RNA (shRNA)-based strategies, his work aims to develop innovative therapeutic solutions for viral and immunological diseases. Known for his meticulous research approach and organizational skills, he has made significant contributions to biomedical engineering and immunotherapy.

Professional profile👤

Google Scholar

ORCID

Strengths for the Awards✨

  • Extensive Research Experience:

    • Over two decades of experience in biomedical research, with a focus on virology, RNA analysis, and immunological diseases.

    • Leadership roles as a Principal Investigator, Research Coordinator, and Senior Researcher.

  • Significant Contributions to Scientific Knowledge:

    • Multiple peer-reviewed publications in well-regarded journals.

    • Research in shRNA-based antiviral therapies and autophagy in liver fibrosis, which have important clinical implications.

  • Teaching and Mentorship:

    • Experience teaching undergraduate and graduate students in microbiology, virology, medical biotechnology, and related fields.

    • Conducted training sessions in advanced molecular biology techniques such as PCR, ELISA, gene cloning, and viral culture methods.

  • Technical Expertise:

    • Skilled in molecular biology, viral diagnostics, and gene therapy techniques.

    • Proficient in specialized software for bioinformatics and data analysis

Education 🎓

Dr. Amiri Zadeh Fard holds a Ph.D. in Medical Virology from Shiraz University of Medical Sciences (2018-2023). He also earned an M.Sc. in Bacteriology from Shahre-Kord University of Medical Sciences (2016-2018), a B.Sc. from Shiraz Azad University (2011-2016), and an Associate Degree from Bandar Abbas University of Medical Sciences (1995-1998).

Experience 🌟

Dr. Amiri Zadeh Fard has held key research positions at the Gastroenterohepathology Research Center, Iran, since 2008. He has served as Principal Investigator, Research Coordinator, and Senior Researcher, significantly enhancing research efficiency through advanced viral analysis methods. Additionally, his role as a Laboratory Instructor and Technician has allowed him to mentor students and improve laboratory processes.

Research Interests On Microbiology🔬

His research focuses on biomedical engineering, virology, and biotechnology, particularly on shRNA-mediated viral suppression. His expertise spans DNA and RNA analysis, viral culture, gene cloning, and the development of novel therapeutic interventions for immunological diseases.

Awards & Honors 🏆

Dr. Amiri Zadeh Fard has received multiple accolades for his pioneering research in virology and biotechnology. His contributions to shRNA-based antiviral strategies have been widely recognized in the scientific community, earning him invitations as a reviewer for prestigious journals such as Clinica Chimica Acta.

Publications 📚

  • Therapeutic and Adverse Effects of Glucantime Used for Treatment of Cutaneous Leishmaniasis
    Authors: AS Beheshti M, Ghotbi Sh
    Year: 2007
    Citations: 25

  • Effects of three months of treatment with vitamin E and N-acetyl cysteine on the oxidative balance in patients with transfusion-dependent β-thalassemia
    Authors: S Haghpanah, N Cohan, M Bordbar, A Bazrafshan, M Karimi, S Zareifar, …
    Year: 2021
    Citations: 12

  • Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran
    Authors: KB Lankarani, B Honarvar, HM Vardanjani, A Kharmandar, MM Gouya, …
    Year: 2020
    Citations: 11

  • Value of serological biomarker panel in diagnosis of atrophic gastritis and Helicobacter pylori Infection
    Authors: GR Sivandzadeh, SAZ Fard, A Zahmatkesh, MH Anbardar, KB Lankarani
    Year: 2023
    Citations: 7

  • Predictors of death in the liver transplantation adult candidates: an artificial neural networks and support vector machine hybrid-based cohort study
    Authors: KB Lankarani, B Honarvar, FS Pour, M Bagherpour, A Erjaee, …
    Year: 2022
    Citations: 4

  • Sustained Suppression of Fusion Gene‑mediated Human Respiratory Syncytial Virus Load by shRNA‑based Therapeutics
    Authors: ABB Amiri Zadeh S, Haniyeh Abuei, Ali Farhadi, Gholamreza Rafiei …
    Year: 2023
    Citations: 3*

  • Unlocking therapeutic potential: enhanced shRNA delivery with Tat peptide in the human respiratory Syncytial Virus Treatment
    Authors: SAZ Fard, H Abuei, AB Behbahani, GR Dehbidi, F Zare, M Nejabat, …
    Year: 2024
    Citations: 2

  • The Potential Role of Autophagy in Progression of Liver Fibrosis in Chronic Hepatitis B Patients Receiving Antiviral Treatment: A Brief Report
    Authors: KB Lankarani, A Sadidoost, M Fattahi, SA Fard, P Mokarram
    Year: 2024
    Citations: 1

  • Short hairpin RNA-mediated matrix gene silencing of human respiratory syncytial virus as a potent antiviral strategy
    Authors: ZAABB Saeid Amiri Zadeh Fard, Haniyeh Abuei, Ali Farhadi, Gholamreza …
    Year: 2023
    Citations: 1

  • Helicobacter pylori infection and inflammatory bowel disease: is there a link?
    Authors: M Nejabat, SAZ Fard, A Safarpour, SA Jirandeh
    Year: 2018
    Citations: 1

Conclusion 🎯

Dr. Saeid Amiri Zadeh Fard is a passionate researcher dedicated to advancing virology and biomedical engineering. His expertise in RNA-based therapeutics and extensive contributions to scientific research make him a valuable asset to the field. His leadership in research coordination and laboratory management continues to drive impactful discoveries in viral immunotherapy.

Yun zou | Microbiology | Best Researcher Award

Posted on by sciencefather

Mr. Yun zou | Microbiology | Best Researcher Award

The General Hospital of Western Theater Command | China

Zou Xinyun is a Master’s degree candidate and Chief Technician with a strong background in oncology and biomedical engineering. Since graduating from Hubei University of Science and Technology in 2011, he has been dedicated to medical research and clinical practice at the General Hospital of the Western Theater Command of the Chinese People’s Liberation Army. Currently, he is pursuing his Master’s degree in Biomedical Engineering at the School of Medicine, Southwest Jiaotong University, under the guidance of Professor Zhang Ling. His research contributions have been recognized through multiple prestigious awards and numerous scientific publications.

Profile👤

ORCID

Strengths for the Awards✨

  • Extensive Research Contributions 📚

    • Zou Xinyun has published five SCI papers as the first author in reputable journals, including Translational Cancer Research, Discover Oncology, and Clinical and Experimental Hypertension.
    • He has also co-authored several other publications, demonstrating his active involvement in collaborative research.

  • Academic Excellence & Recognition 🎓

    • He is a National Graduate Scholarship recipient, which highlights his academic excellence and dedication to research.
    • Recognized as an Outstanding Graduate of Hubei University of Science and Technology and an Excellent Medical Worker at his hospital, indicating his exceptional contributions to both research and clinical practice.

  • Strong Clinical and Research Background 🏥

    • With over a decade of experience at the Department of Oncology in a leading military hospital, he has gained deep expertise in clinical oncology research.
    • His ongoing Master’s in Biomedical Engineering at Southwest Jiaotong University under Professor Zhang Ling demonstrates a strong interdisciplinary approach to cancer research.
  • Zou Xinyun has an impressive research profile, particularly in oncology and biomedical engineering, with multiple SCI-indexed publications, academic excellence awards, and clinical research experience. While he is a strong candidate for the Best Researcher Award, focusing on high-impact publications, independent funding, and broader collaborations could further solidify his position as a top-tier researcher in his field.

🎓 Education

  • Bachelor’s Degree (2011) – Hubei University of Science and Technology
  • Master’s Degree Candidate (2021–2024) – School of Medicine, Southwest Jiaotong University
    • Research supervised by Professor Zhang Ling
    • Specializing in Biomedical Engineering

🏥 Experience

  • 2011–Present: Chief Technician, Department of Oncology, General Hospital of the Western Theater Command, Chinese People’s Liberation Army
    • Over a decade of experience in oncology research and clinical applications
    • Involved in advanced medical diagnostics and cancer treatment strategies

🔬 Research Interests On Microbiology

Zou Xinyun’s research focuses on oncology, biomedical engineering, and clinical cancer treatment. His work explores innovative approaches in cancer diagnostics, therapeutic interventions, and biomedical applications to improve patient outcomes. He is particularly interested in translational cancer research and the development of novel treatment methodologies.

🏆 Awards & Honors

  • 🏅 Outstanding Graduate – Hubei University of Science and Technology
  • 🏅 Excellent Medical Worker – General Hospital of the Western Theater Command
  • 🏅 National Graduate Scholarship – Recognized for academic excellence and research contributions

📚 Publications

  • Title: Association between immune cells and endometrial cancer: A bidirectional Mendelian randomization study

    • Authors: Xinyun Zou, Jinlan Shen, Hengdi Zhang, Fangyuan Kong, Xuemei Jin, Ling Zhang
    • Year: 2024
    • Citations: Not provided

  • Title: The causal effects of immune cells on pancreatic cancer: A 2‑sample Mendelian randomization study

    • Authors: Zou X, Shen J, Yong X, Diao Y, Ling Zhang
    • Year: 2024
    • Citations: Not provided

  • Title: Emodin ameliorates myocardial fibrosis in mice by inactivating the ROS/PI3K/Akt/mTOR axis

    • Authors: Huang W, Zhou P, Zou X, Liu Y, Zhou L, Zhang Y
    • Year: 2024
    • Citations: Not provided

  • Title: Radiomics in Nasopharyngeal Carcinoma

    • Authors: Wenyue Duan, Xiong B, Tian T, Zou X, He Z, Ling Zhang
    • Year: 2022
    • Citations: Not provided

🔚 Conclusion

Zou Xinyun is a dedicated researcher and medical professional with a strong commitment to oncology and biomedical engineering. His contributions to cancer research, coupled with his clinical expertise, have earned him significant recognition in the medical field. With a solid track record of academic excellence, professional experience, and impactful publications, he continues to advance medical science and improve patient care.